Stocks TelegraphStocks Telegraph
Stock Ideas

SHIEF Financial Statements and Analysis

PNK : SHIEF

Shield Therapeutics

$0.02
00
At Close 4:00 PM

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2019
reported currencyUSDGBPGBPGBPGBP
calendar year20262025202420232019
periodQ2Q2Q2Q2Q2
revenue30.122M16.54M9.592M3.515M0
cost of revenue12.631M8.921M5.278M2.092M0
gross profit17.491M7.619M4.315M1.422M0
gross profit ratio0.5810.4610.450.4050
research and development expenses928.329K571.453K594.568K351.936K0
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses16.356M11.513M14.876M13.914M0
other expenses00000
operating expenses17.284M12.085M15.471M14.266M0
cost and expenses29.915M21.006M20.748M16.359M0
interest income9.918K130.331K160.501K264.358K0
interest expense2.254M2.896M1.285M468.708K0
depreciation and amortization476.066K546.003K475.18K424.919K0
ebitda683.353K-3.79M-10.681M-12.419M0
ebitda ratio0.023-0.229-1.114-3.5340
operating income207.286K-4.466M-11.156M-12.844M0
operating income ratio0.007-0.27-1.163-3.6550
total other income expenses net-2.244M-2.765M-1.083M3.281M0
income before tax-2.037M-7.231M-12.239M-9.563M0
income before tax ratio-0.068-0.437-1.276-2.7210
income tax expense197.368K121.848K-1.581K658.462K0
net income-2.235M-7.353M-12.238M-10.222M0
net income ratio-0.074-0.445-1.276-2.9080
eps-0.002-0.007-0.016-0.0150
eps diluted-0.002-0.007-0.016-0.0150
weighted average shs out1.069B1.042B782.056M702.902M0
weighted average shs out dil1.069B1.042B782.056M702.902M0
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Dec 31, 2022
reported currencyUSDUSDGBPGBPGBP
calendar year20262025202420232022
periodQ2Q2Q2Q2Q4
cash and cash equivalents8.388M10.814M6.407M13.594M2.821M
short term investments00000
cash and short term investments8.388M10.814M6.407M13.594M2.821M
net receivables16.999M23.693M12.421M7.718M0
inventory9.156M6.748M3.192M2.695M1.457M
other current assets0108.00K1.002.094M0
total current assets34.543M41.363M22.02M26.101M10.094M
property plant equipment net111.575K228.00K414.524K327.00K197.00K
goodwill00000
intangible assets18.263M19.508M015.239M11.783M
goodwill and intangible assets18.263M19.508M015.239M11.783M
long term investments1.005M729.74K791.076K00
tax assets00000
other non current assets0270.26K13.766M00
total non current assets19.38M20.736M14.971M15.566M11.98M
other assets001.0000
total assets53.923M62.099M36.992M41.667M22.074M
account payables10.588M16.098M08.08M9.489M
short term debt099.00K230.994K67.00K89.00K
tax payables058.00K00224.00K
deferred revenue00000
other current liabilities35.416M33.752M20.765M713.00K1.061M
total current liabilities46.004M50.007M20.996M8.86M10.639M
long term debt25.032M26.949M15.568M5.705M6.008M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities25.032M26.949M15.568M5.705M6.008M
other liabilities001.0000
capital lease obligations099.00K067.00K89.00K
total liabilities71.036M76.956M36.564M14.565M16.647M
preferred stock00000
common stock20.582M19.908M11.875M13.734M3.891M
retained earnings-236.474M-269.015M-162.312M-213.288M-146.638M
accumulated other comprehensive income loss-6.905M-8.887M-6.368M8.34M0
other total stockholders equity205.684M234.25M157.234M218.316M148.174M
total stockholders equity-17.112M-14.857M427.972K27.102M5.427M
total equity-17.112M-14.857M427.972K27.102M5.427M
total liabilities and stockholders equity53.923M62.099M36.992M41.667M22.074M
minority interest00000
total investments1.005M729.74K791.076K00
total debt25.032M27.048M15.799M5.772M6.097M
net debt16.644M16.234M9.392M-7.822M3.276M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023
reported currencyUSDGBPGBPGBP
calendar year2026202520242023
periodQ2Q2Q2Q2
deferred income tax0000
stock based compensation0000
change in working capital1.729M1.757M7.207M-7.344M
accounts receivables7.193M-4.005M-1.509M-2.929M
inventory104.138K-552.944K-657.82K-760.637K
accounts payables-7.738M5.558M5.252M-2.728M
other working capital2.17M756.539K4.121M-926.065K
other non cash items769.641K556.03K-856.272K1.271M
net cash provided by operating activities739.886K-4.495M-3.276M-15.87M
investments in property plant and equipment-110.089K-1.012M-800.136K-1.333M
acquisitions net0000
purchases of investments00-790.649K0
sales maturities of investments0000
other investing activites0000
net cash used for investing activites-110.089K-1.012M-1.591M-1.333M
debt repayment-4.676M00-8.109M
common stock issued49.589K000
common stock repurchased0000
dividends paid0000
other financing activites07.575M016.356M
net cash used provided by financing activities-4.627M7.575M-92.505K24.433M
effect of forex changes on cash858.556K213.875K0641.457K
net change in cash-3.138M2.283M-4.534M7.872M
cash at end of period8.388M7.891M6.407M10.693M
cash at beginning of period11.527M5.608M10.941M2.821M
operating cashflow739.886K-4.495M-3.276M-15.87M
capital expenditure-27.775K-4.00-800.136K-1.333M
free cash flow712.11K-4.495M-4.077M-17.203M
Graph

Frequently Asked Questions

How did Shield Therapeutics plc do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, SHIEF generated $30.12M in revenue last quarter, while its costs came in at $12.63M.
Last quarter, how much Gross Profit did Shield Therapeutics plc report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Shield Therapeutics plc reported a $17.49M Gross Profit for the quarter ended Jun 30, 2026.
Have SHIEF's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. SHIEF incurred $17.28M worth of Operating Expenses, while it generated $207.29K worth of Operating Income.
How much Net Income has SHIEF posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Shield Therapeutics plc, the company generated -$2.23M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Shield Therapeutics plc have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Shield Therapeutics plc as of the end of the last quarter was $8.39M.
What are SHIEF's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, SHIEF had Total Net Receivables of $17.00M.
In terms of Total Assets and Current Assets, where did Shield Therapeutics plc stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of SHIEF were $34.54M, while the Total Assets stand at $53.92M.
As of the last quarter, how much Total Debt did Shield Therapeutics plc have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of SHIEF's debt was $25.03M at the end of the last quarter.
What were SHIEF's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, SHIEF reported total liabilities of $71.04M.
How much did SHIEF's Working Capital change over the last quarter?
Working Capital Change for SHIEF was $1.73M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
SHIEF generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. SHIEF generated $739.89K of Cash from Operating Activities during its recently reported quarter.
What was SHIEF's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. SHIEF reported a -$3.14M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph